MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circoutcomes.110.942318

Медицинская библиотека · Circulation. Cardiovascular quality and outcomes · 2010

Physician and patient influences on provider performance: β-blockers in postmyocardial infarction management in the MI-Plus study.

Funkhouser Ellen, Houston Thomas K, Levine Deborah A, Richman Joshua, Allison Jeroan J, Kiefe Catarina I

СтатьяПоддержка NIH: внешняя программаПоддержка правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Efforts to improve the quality of care for patients with cardiovascular disease frequently target the decrease of physician-level performance variability. We assessed how variability in providing β-blockers to ambulatory postmyocardial infarction (MI) patients was influenced by physician and patient level characteristics.

METHODS AND

RESULTS

β-Blocker prescription and patient characteristics were abstracted from charts of post-MI patients treated by 133 primary care physicians between 2003 and 2007 and linked to physician and practice characteristics. Associations of β-blocker prescription with physician- and patient-level characteristics were examined using mixed-effects models, with physician-level effects as random. Mean physician-specific predicted probabilities and the intraclass correlations, which assessed the proportion of variance explainable at the physician level, were estimated. Of 1901 patients without major contraindication, 69.1% (range across physicians, 20% to 100%) were prescribed β-blockers. Prescription varied with comorbidity from 78.3% in patients with chronic kidney disease to 54.7% for patients with stroke. Although physician characteristics such as older physician age, group practice, and rural location were each positively associated with β-blocker prescription, physician factors accounted for only 5% to 8% of the variance in β-blocker prescription; the preponderance of the variance, 92% to 95%, was at the patient level. The mean physician-specific probability of β-blocker prescription (95% confidence interval) in the fully adjusted model was 63% (61% to 65%).

CONCLUSIONS

β-Blocker prescription rates were surprisingly low. The contribution of physician factors to overall variability in β-blocker prescription, however, was limited. Increasing evidence-based use of β-blockers may not be accomplished by focusing mostly on differential performance across physicians.

Для цитирования: Funkhouser Ellen, Houston Thomas K, Levine Deborah A, Richman Joshua, Allison Jeroan J, Kiefe Catarina I. Physician and patient influences on provider performance: β-blockers in postmyocardial infarction management in the MI-Plus study.. Circulation. Cardiovascular quality and outcomes. 2010. DOI: 10.1161/circoutcomes.110.942318.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.